chevron_left
Relapsed and Refractory AML
adjust
1. If remission rates are high in AML, why are many patients not cured? Video
bookmark_border
2. What are the strategies for patients who have relapsed? Video
bookmark_border
3. BETA - What is the definition of relapsed AML? Video
bookmark_border
4. BETA - What is the difference between relapsed and refractory AML? Video
bookmark_border
5. How do I know what my risk of relapse is? Video
bookmark_border
6. How do I know if my AML has relapsed? Video
bookmark_border
7. Why do you become refractory to a drug? Video
bookmark_border
8. How often are patients refractory to induction therapy and if this happens, what’s next for these patients? Video
bookmark_border
9. What are the next steps if I relapse after taking hypomethylating agents with or without venetoclax? Video
bookmark_border
10. Do individuals become refractory to a specific drug or an entire class of drugs? Video
bookmark_border
11. If I relapse, is the previous treatment given again or should I consider a new therapy? Video
bookmark_border
12. What are the newest drugs for relapsed/refractory AML? Which are some promising drugs in development? Video
bookmark_border
13. When should a patient consider a clinical trial if they relapse? Video
bookmark_border
14. What are some tips or strategies for coping with the ongoing fear of relapse? Video
bookmark_border![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}